Drug prevents bone loss in prostate cancer: Amgen (Reuters)

[riky]

Drug prevents bone loss in prostate cancer: Amgen
    (Reuters)

 


Reuters - Amgen Inc on Monday said that a trial
of its experimental drug denosumab showed that it can prevent
osteoporosis in men being treated with prostate cancer drugs
that can cause bone loss.


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20080714/hl_nm/amgen_denosumab_dc